You are browsing articles on the topic of General Archives - CardioExchange

Avatar of Richard Lehman, BM, BCh, MRCGP

Selections from Richard Lehman’s Literature Review: December 8th (8 Dec 2014)

Voices

Richard Lehman, BM, BCh, MRCGP

This week’s topics include the surgical treatment of moderate ischemic mitral regurgitation, the Mediterranean diet and telomere length, and more.

Avatar of CardioExchange Editors, Staff

I’m glad someone still reads paper journals! (8 Dec 2014)

CardioExchange Editors, Staff

In the digital age it’s easy to forget the joyful innocence of physical print.

Avatar of Larry Husten, PHD

Intent to Tweet and a Failure of Communication (4 Dec 2014)

Voices

Larry Husten, PhD

Larry Husten discusses the challenges those in traditional medicine have with using social media to promote research.

Avatar of Larry Husten, PHD

Adherence to Mediterranean Diet Linked to Marker of Healthy Aging (2 Dec 2014)

News

Following a string of recent successes and favorable publicity for the Mediterranean Diet, a a new study published in The BMJ finds that women who more closely followed a Mediterranean diet had longer telomeres, a key measure of healthy aging. The new report is based on data from 4676 women in the Nurses’ Health Study who completed…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Richard Lehman, BM, BCh, MRCGP

Selections from Richard Lehman’s Literature Review: December 1st (1 Dec 2014)

Voices

Richard Lehman, BM, BCh, MRCGP

This week’s topics include atenolol vs. losartan in children and young adults with Marfan’s syndrome, the Japanese Primary Prevention Project, and more.

Avatar of Larry Husten, PHD

Study Suggests Epinephrine for Cardiac Arrest May Be Harmful (1 Dec 2014)

News

Epinephrine has been a cornerstone of therapy during cardiac resuscitation after cardiac arrest because of its well-established ability to stimulate the heart and increase the probability of a return of spontaneous circulation (ROSC). In recent years, however, concerns have been raised that people treated with epinephrine may have worse neurological outcomes following their resuscitation. In…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Richard Lehman, BM, BCh, MRCGP

Selections from Richard Lehman’s Literature Review: November 24th (24 Nov 2014)

Voices

Richard Lehman, BM, BCh, MRCGP

This week’s topics include the PROTECT-AF trial, the association of inpatient vs. outpatient onset of STEMI with treatment and clinical outcomes, and more.

Avatar of Larry Husten, PHD

European Review Confirms Increased Risk with Ivabradine (24 Nov 2014)

News

Following a review provoked by troubling findings that emerged from a large clinical trial, the European Medicines Agency (EMA) is making several recommendations intended to lower the risk of heart problems linked to the heart-rate-lowering drug ivabradine. The drug is marketed by Servier in Europe under the brand names of Corlentor and Procoralan and is indicated for…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Larry Husten, PHD

Encouraging Results for Two New Drugs for Hyperkalemia (21 Nov 2014)

News

Two new agents under development may help curb and prevent hyperkalemia, the common and serious side effect of drugs that inhibit the renin-angiotensin-aldosterone system (RAAS), which are the cornerstones of the treatment of chronic kidney disease and heart failure. In a phase 3 study, published online in the New England Journal of Medicine, researchers first randomized…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Larry Husten, PHD

Encouraging Results For Two New Drugs For Hyperkalemia (21 Nov 2014)

News

Two new agents under development may help curb and prevent hyperkalemia, the common and serious side effect of drugs that inhibit the renin-angiotensin-aldosterone system (RAAS), which are the cornerstones of the treatment of chronic kidney disease and heart failure. … Click here to read the full post on Forbes.